Provided by Tiger Fintech (Singapore) Pte. Ltd.

Novartis AG

117.79
+0.85000.73%
Post-market: 117.790.00000.00%19:53 EDT
Volume:1.07M
Turnover:126.28M
Market Cap:230.78B
PE:18.47
High:118.25
Open:117.49
Low:117.10
Close:116.94
Loading ...

Novartis (NVS) is a Great Momentum Stock: Should You Buy?

Zacks
·
06 May

Why Novartis (NVS) is a Great Dividend Stock Right Now

Zacks
·
05 May

India Offers US Reciprocal Zero Tariffs on Steel, Auto Parts, Pharmaceutical Drugs, Bloomberg Reports

MT Newswires Live
·
05 May

BioNTech Names Ramon Zapata-Gomez as Chief Financial Officer

MT Newswires Live
·
05 May

Trump Says Drug Tariffs Are Coming. Big Pharma Execs Can't Figure Out How Much to Worry. -- Barrons.com

Dow Jones
·
03 May

Pharma Stocks Rallied. Novo-Nordisk up 6%; Eli Lilly and Viking up 4%; Moderna, Novavax And BioNTech up 1%.

Tiger Newspress
·
02 May

Novartis to buy Regulus Therapeutics for as much as $1.7 billion

LA Times
·
02 May

Biotech Alert: Searches spiking for these stocks today

TipRanks
·
02 May

Pharma Stocks Sank. Eli Lilly Fell 7%; Moderna Fell 5%; Novavax And BioNTech Fell 4%; Viking Fell 2%

Tiger Newspress
·
01 May

Top Midday Gainers

MT Newswires Live
·
01 May

Humana Does Not Alter 2025 Outlook Despite Sales Miss And Medicare Membership Decline

Benzinga
·
01 May

Regulus Shares Surge on $1.7 Billion Acquisition by Novartis

Dow Jones
·
01 May

Novartis to Buy Regulus Therapeutics for up to $1.7 Billion

Reuters
·
30 Apr

Why Novartis (NVS) is a Top Value Stock for the Long-Term

Zacks
·
30 Apr

Novartis to Acquire Regulus in $1.7B Deal

Dow Jones
·
30 Apr

Novartis to Acquire Regulus Therapeutics

MT Newswires Live
·
30 Apr

Novartis to acquire Regulus Therapeutics and farabursen, an investigational microRNA inhibitor to treat ADPKD, the most common genetic cause of renal failure

GlobeNewswire
·
30 Apr

Novartis Q1 Earnings Beat Street View, CEO 'Confident' In Delivering Upgraded Guidance

Benzinga
·
30 Apr

Novartis reports Q1 core EPS $2.28, consensus $2.11

TIPRANKS
·
29 Apr

Compared to Estimates, Novartis (NVS) Q1 Earnings: A Look at Key Metrics

Zacks
·
29 Apr